To Tad's credit, there is no mention of FINRA approval. But which "regulatory" agency(s)? 3/20/23 - Tad Mailander, CEO of Plandai Biotechnology. "We are excited about the potential opportunities this new direction presents and are committed to leveraging our combined expertise and resources to drive innovation and growth................. In preparation for the closing of the agreement, Plandai has filed a corporate action to change its name to ByoPlanet, Inc. and has requested a new trading symbol. These changes are currently awaiting regulatory approval, and the company looks forward to providing further updates to its stakeholders as they become available.https://finance.yahoo.com/news/plandai-biotechnology-inc-announces-entry-110000183.html